Osteopontin levels are elevated in patients with eosinophilic pneumonia

Respirology

Volumn 15, Issue 7, 2010, Pages 1111-1121

  Ueno, Takuya ^a   Miyazaki, Eishi ^a   Ando, Masaru ^a   Nureki, Shin Ichi ^a   Kumamoto, Toshihide ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

cytokine; eosinophil; interstitial lung disease; osteopontin; pneumonia

Indexed keywords

CORTICOSTEROID; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; OSTEOPONTIN; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DRUG INDUCED DISEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LOEFFLER PNEUMONIA; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SARCOIDOSIS;

ACUTE DISEASE; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ALVEOLITIS, EXTRINSIC ALLERGIC; BRONCHOALVEOLAR LAVAGE FLUID; CHRONIC DISEASE; CYTOKINES; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; OSTEOPONTIN; PULMONARY EOSINOPHILIA; RETROSPECTIVE STUDIES; SARCOIDOSIS; SMOKING; YOUNG ADULT;

EID: 77957270385     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01825.x     Document Type: Article

References (47)

1. Denhardt DT, Noda M, O'Regan AW et al. OPN as a means to cope with enviromental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest. 2001 107 : 1055 61. (Pubitemid 32422899)
2. O'Regan AW, Nau GJ, Chupp GL et al. Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. Immunol. Today 2000 21 : 475 8.
3. Ashkar S, Weber GF, Panoutsakopoulou V et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000 287 : 860 4. (Pubitemid 30084330)
4. O'Regan AW, Chupp GL, Lowry JA et al. Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J. Immunol. 1999 162 : 1024 31.
5. Koguchi Y, Kawakami K, Uezu K et al. High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis. Am. J. Respir. Crit. Care Med. 2003 167 : 1355 9. (Pubitemid 36609719)
6. Uchio E, Matsuura N, Kadonosono K et al. Tear osteopontin levels in patients with allergic conjunctival diseases. Graefes. Arch. Clin. Exp. Ophthalmol. 2002 240 : 924 8. (Pubitemid 36097116)
7. Kohan M, Bader R, Puxeddu I et al. Enhanced osteopontin expression in a murine model of allergen-induced airway remodelling. Clin. Exp. Allergy 2007 37 : 1444 54. (Pubitemid 47460229)
8. Xanthou G, Alissafi T, Semitekolou M et al. Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat. Med. 2007 13 : 570 8. (Pubitemid 46828486)
9. Lu X, Zhang XH, Wang H et al. Expression of osteopontin in chronic rhinosinusitis with and without nasal polyps. Allergy 2009 64 : 104 11.
10. Allen J, Davis W. The eosinophilic lung diseases. Am. J. Respir. Crit. Care Med. 1994 150 : 1423 38.
11. Cooper JA Jr., White DA, Matthay RA. Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs. Am. Rev. Respir. Dis. 1986 133 : 488 505. (Pubitemid 16126287)
12. Rom WN, Weiden M, Garcia R et al. Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust. Am. J. Respir. Crit. Care Med. 2002 166 : 797 800.
13. Carrington CB, Addington WW, Groff AM et al. Chronic eosinophilic pneumonia. N. Engl. J. Med. 1969 280 : 787 98.
14. Allen JN, Pacht ER, Gadek JE et al. Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure. N. Engl. J. Med. 1989 321 : 569 74.
15. Badesch D, King TJ, Schwarz M. Acute eosinophilic pneumonia: a hypersensitivity phenomenon? Am. Rev. Respir. Dis. 1989 139 : 249 52. (Pubitemid 19030453)
16. Allen J. Acute eosinophilic pneumonia. Semin. Respir. Crit. Care Med. 2006 27 : 142 7.
17. Philit F, Etienne-Mastroïanni B, Parrot A et al. Idiopathic acute eosinophilic pneumonia: a study of 22 patients. Am. J. Respir. Crit. Care Med. 2002 166 : 1235 9. (Pubitemid 35222601)
18. Pope-Harman AL, Davis WB, Allen ED et al. Acute eosinophilic pneumonia. A summary of 15 cases and review of the literature. Medicine (Baltimore) 1996 75 : 334 42.
19. Uchiyama H, Suda T, Nakamura Y et al. Alterations in smoking habits are associated with acute eosinophilic pneumonia. Chest 2008 133 : 1174 80. (Pubitemid 351685523)
20. Shintani H, Fujimura M, Ishiura Y et al. A case of cigarette smoking-induced acute eosinophilic pneumonia showing tolerance. Chest 2000 117 : 277 9. (Pubitemid 30053652)
21. Mochimaru H, Kawamoto M, Fukuda Y et al. Clinicopathological differences between acute and chronic eosinophilic pneumonia. Respirology 2005 10 : 76 85. (Pubitemid 40343766)
22. Walker C, Bauer W, Braun RK et al. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am. J. Respir. Crit. Care Med. 1994 150 : 1038 48. (Pubitemid 24318033)
23. Miyazaki E, Nureki S, Fukami T et al. Elevated levels of thymus- and activation-regulated chemokine in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia. Am. J. Respir. Crit. Care Med. 2002 165 : 1125 31. (Pubitemid 34415822)
24. Katoh S, Fukushima K, Matsumoto N et al. Accumulation of CCR4-expressing CD4+ T cells and high concentration of its ligands (TARC and MDC) in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. Allergy 2003 58 : 518 23. (Pubitemid 36649314)
25. Nureki S, Miyazaki E, Ando M et al. CC chemokine receptor 4 ligand production by bronchoalveolar lavage fluid cells in cigarette-smoke-associated acute eosinophilic pneumonia. Clin. Immunol. 2005 116. (Pubitemid 40733586)
26. Sennels H, Sørensen S, Ostergaard M et al. Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate. Scand. J. Rheumatol. 2008 37 : 241 7. (Pubitemid 351962322)
27. Chang YS, Kim HJ, Chang J et al. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer. Lung Cancer 2007 57 : 373 80. (Pubitemid 47285428)
28. Wong CK, Lit LC, Tam LS et al. Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2005 44 : 602 6.
29. Hayami T, Zhang Q, Kapila Y et al. Dexamethasone's enhancement of osteoblastic markers in human periodontal ligament cells is associated with inhibition of collagenase expression. Bone 2007 40 : 93 104. (Pubitemid 44839327)
30. Kirton JP, Wilkinson FL, Canfield AE et al. Dexamethasone downregulates calcification-inhibitor molecules and accelerates osteogenic differentiation of vascular pericytes: implications for vascular calcification. Circ. Res. 2006 98 : 1264 72.
31. Kurokawa M, Konno S, Matsukura S et al. Effects of corticosteroids on osteopontin expression in a murine model of allergic asthma. Int. Arch. Allergy Immunol. 2009 149 : 7 13.
32. Brown LF, Berse B, Van de Water L et al. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol. Biol. Cell 1992 3 : 1169 80. (Pubitemid 23088966)
33. Katoh S, Matsumoto N, Fukushima K et al. Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. J. Allergy Clin. Immunol. 2000 106 : 730 6. (Pubitemid 39005826)
34. Puxeddu I, Berkman N, Ribatti D et al. Osteopontin is expressed and functional in human eosinophils. Allergy 2010 65 : 168 74.
35. Takahashi A, Kurokawa M, Konno S et al. Osteopontin is involved in migration of eosinophils in asthma. Clin. Exp. Allergy 2009 39 : 1152 9.
36. Sallusto F, Lenig D, Mackay CR et al. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 1998 187 : 875 83. (Pubitemid 28141661)
37. Deng W, Ohmori Y, Hamilton TA. Mechanisms of IL-4-mediated suppression of IP-10 gene expression in murine macrophages. J. Immunol. 1994 153 : 2130 6. (Pubitemid 24256684)
38. Katoh S, Fukushima K, Matsumoto N et al. Accumulation of CXCR-3-expressing eosinophils and increased concentration of its ligands (IP-10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia. Int. Arch. Allergy Immunol. 2005 137 : 229 35. (Pubitemid 41202762)
39. Nanki T, Lipsky PE. Lack of correlation between chemokine receptor and T(h)1/T(h)2 cytokine expression by individual memory T cells. Int. Immunol. 2000 12 : 1659 66. (Pubitemid 32007722)
40. Thomas MS, Kunkel SL, Lukacs NW. Differential role of IFN-gamma-inducible protein 10 kDa in a cockroach antigen-induced model of allergic airway hyperreactivity: systemic versus local effects. J. Immunol. 2002 169 : 7045 53.
41. Jinquan T, Jing C, Jacobi HH et al. CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma. J. Immunol. 2000 165 : 1548 56. (Pubitemid 30604591)
42. Sedgwick JB, Menon I, Gern JE et al. Effects of inflammatory cytokines on the permeability of human lung microvascular endothelial cell monolayers and differential eosinophil transmigration. J. Allergy Clin. Immunol. 2002 110 : 752 6. (Pubitemid 35423178)
43. Konno S, Eckman JA, Plunkett B et al. Interleukin-10 and Th2 cytokines differentially regulate osteopontin expression in human monocytes and dendritic cells. J. Interferon Cytokine Res. 2006 26 : 562 7. (Pubitemid 44289898)
44. Kadota J, Mizunoe S, Mito K et al. High plasma concentrations of osteopontin in patients with interstitial pneumonia. Respir. Med. 2005 99 : 111 17. (Pubitemid 40017394)
45. Rennard S, Basset G, Lecossier D et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 1986 60. (Pubitemid 16019939)
46. Creaney J, Robinson BW. Serum and pleural fluid biomarkers for mesothelioma. Curr. Opin. Pulm. Med. 2009 15 : 366 70.
47. Isa S, Kawaguchi T, Teramukai S et al. Serum osteopontin levels are highly prognostic for survival in advanced non-small cell lung cancer: results from JMTO LC 0004. J. Thorac. Oncol. 2009 4 : 1104 10.